PF-04449913

· Pfizer

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for PF-04449913, covering 2013-04-10 to 2024-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-04449913 Administered Alone In Select Solid Tumors [Phase 1]